Page last updated: 2024-11-02

pioglitazone and Exophthalmos

pioglitazone has been researched along with Exophthalmos in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Exophthalmos: Abnormal protrusion of both eyes; may be caused by endocrine gland malfunction, malignancy, injury, or paralysis of the extrinsic muscles of the eye.

Research Excerpts

ExcerptRelevanceReference
"Thirty-six patients with type 2 diabetes and HbA1c >or= 6."1.33Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes. ( Dorkhan, M; Frid, A; Groop, L; Hallengren, B; Lantz, M, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dorkhan, M1
Lantz, M1
Frid, A1
Groop, L1
Hallengren, B1

Other Studies

1 other study available for pioglitazone and Exophthalmos

ArticleYear
Treatment with a thiazolidinedione increases eye protrusion in a subgroup of patients with type 2 diabetes.
    Clinical endocrinology, 2006, Volume: 65, Issue:1

    Topics: Adiponectin; Aged; Diabetes Mellitus, Type 2; Drug Administration Schedule; Drug Therapy, Combinatio

2006